InhaleRx (ASX:IRX) Change In Receivables : A$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Change In Receivables?

InhaleRx's change in receivables for the quarter that ended in Jun. 2023 was A$0.00 Mil. It means InhaleRx's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

InhaleRx's change in receivables for the fiscal year that ended in Dec. 2023 was A$0.00 Mil. It means InhaleRx's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

InhaleRx's Accounts Receivable for the quarter that ended in Jun. 2023 was A$0.49 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. InhaleRx's liquidation value for the six months ended in Jun. 2023 was A$0.43 Mil.

InhaleRx Change In Receivables Historical Data

The historical data trend for InhaleRx's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Change In Receivables Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial									-	-	-	-	-

InhaleRx Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

InhaleRx (ASX:IRX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

InhaleRx's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.492	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, InhaleRx's accounts receivable are only considered to be worth 75% of book value:

InhaleRx's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.526	-	0.468	+	0.75 * 0.492	+	0.5 * 0
=	0.43

InhaleRx Change In Receivables Related Terms

Thank you for viewing the detailed overview of InhaleRx's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines